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Accepted 14 November 2012AbstractObjective: This study is aimed at prenatal diagnosis of mosaic trisomy 12 and reviewing the literature.
Materials and Methods: A 34-year-old woman underwent amniocentesis at 17 weeks of gestation because of advanced maternal age. Cyto-
genetic analysis of cultured amniocytes revealed a karyotype of 47,XX,þ12[9]/46,XX[14]. She was referred to the hospital for genetic coun-
seling. Repeated amniocentesis was performed at 22 weeks of gestation. Array comparative genomic hybridization (aCGH), interphase
fluorescence in situ hybridization (FISH) and quantitative fluorescent polymerase chain reaction (QF-PCR) were applied on uncultured
amniocytes, and conventional cytogenetic analysis was applied on cultured amniocytes.
Results: The aCGH analysis on uncultured amniocytes revealed a small genomic gain in chromosome 12. Interphase FISH analysis on un-
cultured amniocytes using a 12q11-q12-specific probe of RP11-496H24 (green spectrum) showed three green signals in 17.8% (8/45 cells) of
uncultured amniocytes. QF-PCR analysis on uncultured amniocytes using chromosome 12-specific microsatellite markers excluded uniparental
disomy 12. Cytogenetic analysis of cultured amniocytes revealed a karyotype of 47,XX,þ12[5]/46,XX[25]. The parents decided to continue the
pregnancy. A healthy 3270 g female baby was delivered at 39 weeks of gestation, with no phenotypic abnormalities. Cytogenetic analysis of the
cord blood revealed a karyotype of 46,XX in 40/40 cultured lymphocytes. The neonate was normal in growth and psychomotor development at 6
months of age. Interphase FISH analysis on uncultured urinary cells revealed 5% (1/20 cells) mosaicism for trisomy 12.
Conclusion: Prenatal diagnosis of mosaic trisomy 12 at amniocentesis should alert a clinically significant aneuploidy. Interphase FISH and
aCGH on uncultured amniocytes are useful for rapid confirmation of low-level trisomy 12 mosaicism at repeated amniocentesis.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Fig. 1. Array comparative genomic hybridization analysis on uncultured amniocytes demonstrates a small genomic gain in chromosome 12. (A) Whole genome
view; (B) chromosome view.
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Fig. 3. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction assays on uncultured amniocytes. The markers
D12S1301 and D12S376 show two peaks of equal fluorescent activity from
two different parental alleles in uncultured amniocytes with a dosage ratio of
1:1 (paternal allele:maternal allele).
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tation, retinopathy, and sensorineural hearing loss [11,21e28].
Herein, we present our experience of prenatal diagnosis of
mosaic trisomy 12 by amniocentesis and a review of the
literature.
Materials and methods
A 34-year-old, gravida 3, para 1, woman underwent
amniocentesis at 17 weeks of gestation because of advanced
maternal age. Cytogenetic analysis of cultured amniocytes
revealed a karyotype of 47,XX,þ12[9]/46,XX[14]. She was
referred to the hospital for genetic counseling. The parental
karyotypes were normal, and prenatal ultrasound findings were
unremarkable. Repeated amniocentesis was performed at 22
weeks of gestation. Array comparative genomic hybridization
(aCGH), interphase fluorescence in situ hybridization (FISH)
and quantitative fluorescent polymerase chain reaction
(QF-PCR) were applied on uncultured amniocytes, and con-
ventional cytogenetic analysis was applied on cultured
amniocytes.
Results
The aCGH analysis using CytoChip Oligo Array (Blue-
Gnome, Cambridge, UK) on uncultured amniocytes revealed
a small genomic gain in chromosome 12 (Fig. 1). Interphase
FISH analysis on uncultured amniocytes using a 12q11-q12-
specific probe of RP11-496H24 (green spectrum) showed
three green signals in 17.8% (8/45 cells) and two green signals
in 82.2% (37/45 cells) of uncultured amniocytes (Fig. 2).
QF-PCR analysis on uncultured amniocytes using chromo-
some 12-specific microsatellite markers revealed a 1:1 bipar-
ental diallelic pattern for chromosome 2 and thus excluded
uniparental disomy (UPD) 12 (Fig. 3). Cytogenetic analysis of
cultured amniocytes revealed a karyotype of 47,XX,þ12[5]/Fig. 2. Interphase fluorescence in situ hybridization analysis on uncultured amni
shows: (A) three green signals in a trisomy 12 cell; (B) two green signals in a dis46,XX[25]. Of 30 colonies of cultured amniocytes, five col-
onies (16.7%) had the karyotype of 47,XX,þ12 (Fig. 4),
whereas the other 25 colonies (83.3%) had the karyotype of
46,XX. The parents decided to continue the pregnancy. A
healthy 3270 g female baby was delivered at 39 weeks of
gestation, with no phenotypic abnormalities. Cytogenetic
analysis of cord blood revealed a karyotype of 46,XX in 40/40
cultured lymphocytes. The neonate was normal in growth and
psychomotor development at 6 months of age. Interphase
FISH analysis on uncultured urinary cells at the age of 6
months, using 12q11-q12-specific probe of RP11-496H24ocytes using the a 12q11-q12-specific probe RP11-496H24 (green spectrum)
omy 12 cell.
Fig. 4. A karyotype of 47,XX,þ12.
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cells) and two green signals in 95% (19/20 cells) of urinary
cells, indicating 5% mosaicism for trisomy 12 in the urinary
cells.
Discussion
Molecular cytogenetic techniques, such as aCGH, inter-
phase FISH and QF-PCR, on uncultured amniocytes for rapid
positive confirmation of trisomy mosaicism have been well
described [29e34]. The present case shows that in case of
trisomy 12 at amniocentesis, interphase FISH on uncultured
amniocytes is useful for rapid confirmation of low-level
mosaicism, aCGH on uncultured amniocytes is useful for
confirmation of the presence of about 20% mosaicism, and
QF-PCR assay on uncultured amniocytes is useful for rapid
exclusion of UPD. The present case also provides evidence for
a correlation of low-level trisomy 12 mosaicism in uncultured
amniocytes with a favorable fetal outcome. In the present case,
the first amniocentesis revealed 39.1% (9/23 colonies) mosa-
icism for trisomy 12 in cultured amniocytes, and the second
amniocentesis revealed 16.7% (5/30 colonies) mosaicism for
trisomy 12 in cultured amniocytes and 17.8% (8/45 colonies)
mosaicism for trisomy 12 in uncultured amniocytes detected
by interphase FISH. Different amniocenteses have been
reported to result in inconsistent trisomy 12 mosaicism levels
in cultured amniocytes and make genetic counseling difficult
[7,9,13,20]. For examples, Frohlich and Falk [7] reported 7%
versus 0%, Cartolano et al [9] reported 26.7% versus 0%,
Spiro et al [13] reported 7.5% versus 48%, and Gentilin et al
[20] reported 17.6% versus 62.5% mosaicism for trisomy 12
between two different amniocenteses. We think that interphase
FISH on uncultured amniocytes in repeated amniocentesis is
very practical for determining the real mosaicism level under
such a circumstance.
To date, at least 32 cases of mosaic trisomy 12 detected by
amniocentesis have been reported (Table 1). Of these, at least
nine cases (9/32¼ 28.1%) [3,4,11,14,16,17,19] were associatedwith prominent phenotypic abnormalities, suggesting that the
malformation risk should be concerned in prenatal diagnosis of
mosaic trisomy 12 by amniocentesis. In nine cases with an
apparently abnormal outcome, the percentage of trisomic cells
in cultured amniocytes varied from 4.3% to 61.9% (with 5 cases
>34%). In 23 cases with a normal outcome, the percentage of
trisomic cells in cultured amniocytes varied from 6.1% to
64.3% (with 3 cases > 34%). These findings indicate a corre-
lation between a higher trisomy 12 mosaicism level and an
abnormal fetal outcome. Table 1 shows that the male:female sex
ratio for fetal mosaic trisomy 12 is 0.103 (3 males/29 females),
indicating a female preponderance in fetal mosaic trisomy 12
and a natural selection against male mosaic trisomy 12 con-
ceptuses. Table 1 also shows that mosaic trisomy 12 can pre-
natally be associated with elevated maternal serum a-
fetoprotein [14], elevated maternal serum human chorionic
gonadotrophin [12], abnormal maternal serum screening
[12,14] and abnormal ultrasound findings [2,11,12]. Table 1
additionally shows that the reported abnormal ultrasound
findings associated with mosaic trisomy 12 at amniocentesis
include polyhydramnios, intrauterine growth restriction, single
umbilical artery, congenital heart defects, hydronephrosis and
absence of stomach image.
Mosaic trisomy 12 detected postnatally has been described
in nine cases (2 males/7 females) [11,21e28]. Schinzel [35]
concluded that there is no clinical pattern due to trisomy 12
mosaicism. Richer et al [21] first reported a 31-year-old phe-
notypically normal infertile man with 7% mosaicism for tri-
somy 12 in 157 peripheral blood lymphocytes and Kartagener
syndrome of situs inversus, chorionic sinusitis, bronchitis and
immotile spermatozoa. Patil et al [22] reported a 36-year-old
moderately mentally retarded female with a karyotype of
47,XX,þ12[7]/46,XX[49] in peripheral blood, facial dys-
morphisms, short stature, microcephaly, muscle stiffness,
areflexia limited extension of joints, waddling gaits and sco-
liosis. English et al [23] reported a 7-year-old mentally normal
girl with a karyotype of 47,XX,þ12[6]/46,XX[50] in skin fi-
broblasts, short stature, scoliosis, pigmentary dysplasia and
Table 1
Reported cases of mosaic trisomy 12 detected by amniocentesis.
Authors Cases Indication Amniocentesis studies Confirmatory studies Outcome and phenotype
Jensen et al [1] 47,XX,þ12/46,XX Anxiety Amniocentesis:
T12 ¼ 18% (68 cells)
Cord blood: T12 ¼ 0% (215 cells)
Skin: T12 ¼ 0% (232 cells)
Rib: T12 ¼ 25% (12 cells)
TOP; normal abortus
Leschot et al [2] 47,XX,þ12/46,XX Polyhydramnios Amniocentesis:
T12 ¼ 64.3%
(14 colonies)
Cord blood: T12 ¼ 0% (30 cells)
Skin: T12 ¼ 0% (30 cells)
Urinary cells:
culture A: T12 ¼ 100% (12 cells)
culture B: T12 ¼ 23.3% (30 cells)
Placenta:
culture A: T12 ¼ 31.3% (80 cells)
culture B: T12 ¼ 85% (60 cells)
Normal liveborn with
hypoglycemia and
convulsions after birth but
normal development at age 9
mo
Watson et al [3] Case 2 47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 61.9%
(21 colonies)
Cord blood: T12 ¼ 0% Abnormal liveborn, 33 wk,
1710 g, CHD, cataracts,
horseshoe kidneys, vertebral
anomalies, neonatal death
Von Koskull
et al [4]
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 44% (16 cells)
Cord blood: T12 ¼ 0% (100 cells)
Blood: T12 ¼ 0% (30 cells)
Placenta: T12 ¼ 100% (16 cells)
Urinary cells: T12 ¼ 0% (50 cells)
Skin: T12 ¼ 25% (20 cells)
Abnormal liveborn, CHD,
facial dysmorphism, high
arched palate, long thin
fingers, proximally placed
thumbs, neonatal death
Petrella and
Hirschhorn [5]
47,XX,þ12/46,XX Anxiety Amniocentesis:
T12 ¼ 11.1%
(54 cells)
Skin: T12 ¼ 0% (51 cells)
Kidney: T12 ¼ 0% (50 cells)
Liver: T12 ¼ 0% (18 cells)
Placenta: T12 ¼ 2.6% (39 cells)
TOP; normal abortus
Wyandt et al [6] Case 1
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 6.3%
(32 colonies)
Subcutaneous tissue: T12 ¼ 1.8%
(109 cells)
Bladder: T12 ¼ 0% (70 cells)
Membrane: T12 ¼ 0% (34 cells)
Placenta: T12 ¼ 0% (35 cells)
Peritoneum: T12 ¼ 0% (63 cells)
Blood: T12 ¼ 0% (97 cells)
Lung: T12 ¼ 0% (60 cells)
TOP; normal abortus
Case 2
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 11.1%
(63 cells)
Lung: T12 ¼ 6% (50 cells) TOP; normal abortus
Case 3
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 6.7% (60 cells)
NA TOP; normal abortus
Frohlich and
Falk [7]
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 7% (86 cells)
Retap: T12 ¼ 0%
(200 cells)
Blood: T12 ¼ 0% (100 cells) Normal liveborn, normal
development at age 5 mo
Park et al [8] 47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 6.1% (98 cells)
Blood: T12 ¼ 1% (98 cells)
Skin: T12 ¼ 3% (67 cells)
TOP; normal abortus
Cartolano et al [9] 47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 26.7%
(15 colonies)
Retap: T12 ¼ 0%
(7 colonies)
Cord blood: T12 ¼ 0% (100 cells)
Skin: T12 ¼ 6.7% (15 cells)
Placenta: T12 ¼ 43% (72 cells)
TOP; normal abortus
(continued on next page)
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Table 1 (continued)
Authors Cases Indication Amniocentesis studies Confirmatory studies Outcome and phenotype
Meck et al [10] 47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 22.2%
(36 colonies)
Cord blood: T12 ¼ 0% (20 cells)
Amnion: T12 ¼ 0% (50 cells)
Chorion: T12 ¼ 0% (50 cells)
Placenta: T12 ¼ 0% (51 cells)
Skin: T12 ¼ 0% (100 cells)
Normal liveborn, normal
development at age 5 y
Bischoff et al [11] Case D
47,XX,þ12/46,XX AMA, ultrasound
abnormalities
Amniocentesis:
T12 ¼ 4.3% (47 cells)
Cord blood: T12 ¼ 0% (20 cells)
Cord: T12 ¼ 46.7% (30 cells)
Placenta: T12 ¼ 18.6% (32 cells)
Membrane: T12 ¼ 0% (30 cells)
Ultrasound: CHD, single
umbilical artery,
hydronephrosis.
TOP; abnormal abortus,
IUGR, single umbilical
artery, hydronephrosis, facial
dysmorphism, single palmar
crease, truncus arteriosus
Brosens et al [12] 47,XX,þ12/46,XX AMA, elevated
MSAFP, elevated
MShCG, Down
risk ¼ 1/25,
ultrasound
abnormalities
Amniocentesis:
T12 ¼ 34.8%
(69 cells)
Blood: T12 ¼ 0% (30 cells)
Skin: T12 ¼ 0% (45 cells)
Placenta: T12 ¼ 87.5% (16 cells)
Ultrasound: no fetal stomach
image at 22 wk,
polyhydramnios at 32 wk,
preterm birth
Abnormal liveborn, 32 wk,
1990 g, aortic coarctation,
right ventricular hypertrophy,
tracheo-esophageal fistula,
bilateral pleural effusions,
pericardial effusion, neonatal
death
Spiro et al [13] 47,XX,þ12/45,X/46,XX AMA Amniocentesis:
T12 ¼ 7.5% (40 cells)
Retap: T12 ¼ 48%
(50 cells)
Cord blood: T12 ¼ 0% (50 cells)
Placenta: T12 ¼ 20% (20 cells)
Villi: T12 ¼ 32.5% (40 cells)
Cord: T12 ¼ 85% (20 cells)
Membrane: T12 ¼ 41.7%
(60 cells)
Skin: T12 ¼ 15% (20 cells)
Normal liveborn, mild
physical dysmorphisms,
hypotonia, delay in gross
motor development, age-
appropriate cognitive
development at age 18 mo
Hsu et al [14] Case XI-1
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 14.8%
(27 colonies)
Fetal tissue: T12 ¼ 7.5%
(40 cells)
TOP; normal abortus, single
umbilical artery
Case XI-5
47,XY,þ12/46,XY Abnormal
maternal
serum triple
screen
Amniocentesis:
T12 ¼ 6.3%
(32 colonies)
NA Normal liveborn
Case XI-8
47,XY,þ12/46,XY NA Amniocentesis:
T12 ¼ 33% (30 cells)
Fetal tissue: normal TOP; normal abortus
Case XI-9
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 46.7%
(15 colonies)
NA TOP; normal abortus
Case XI-10
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 50%
(24 colonies)
Retaps: T12 ¼ 53%
T12 ¼ 16%
NA Epstein anomaly, finger
overlapping, normal
psychomotor development at
age 8 mo
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Table 1 (continued )
Authors Cases Indication Amniocentesis studies Confirmatory studies Outcome and phenotype
Case XI-11
47,XX,þ12/46,XX Elevated MSAFP Amniocentesis:
T12 ¼ 12.5%
(16 colonies)
Retaps: T12 ¼ 1.6%
(61 colonies)
NA Normal liveborn
Case XI-12
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 20%
(20 colonies)
Cord blood: T12 ¼ 0%
(30 cells)
Normal liveborn
Case XI-13
47,XY,þ12/46,XY Elevated MSAFP Amniocentesis:
T12 ¼ 28.6%
(14 colonies)
NA Normal liveborn
Case XI-14
47,XX,þ12/46,XX Elevated MSAFP Amniocentesis:
T12 ¼ 23.3%
(43 colonies)
Cord blood: T12 ¼ 0%
(50 cells)
TOP; abnormal abortus,
facial dysmorphism, high
arched palate, clinodactyly,
transverse palmar creases,
short colon, abnormal liver,
CHD, large ovaries
Case XI-18
47,XX,þ12/46,XX Elevated MSAFP Amniocentesis:
T12 ¼ 32.1%
(28 colonies)
NA IUFD, IUGR, no gross
abnormalities
Sikkema-Raddatz
et al [15]
47,XX,þ12/46,XX AMA, mosaic
trisomy
12 at CVS
Amniocentesis:
T12 ¼ 6.9%
(29 colonies)
Cord: T12 ¼ 0%
T12 ¼ 8% (100 cells) (FISH)
TOP; normal abortus
Djalali et al [16] 48,XX,þ12,þ13/46,XX AMA Amniocentesis:
T12 and T13 ¼ 17.7%
(68 cells)
Skin: T12 ¼ 1.3%
(552 cells) (FISH)
Rib: T12 ¼ 2.8%
(108 cells) (FISH)
TOP; abnormal abortus,
facial dysmorphisms
Flore et al [17] 47,XX,þ12/46,XX AMA Amniocentesis:
mosaic T12
Blood: T12 ¼ 0.6%
(interphase cells)
Placenta: T12 ¼ 25%
(cultured cells)
Skin: T12 ¼ 22%
(cultured cells)
TOP; abnormal abortus,
facial dysmorphisms, deep
white matter microinfarct,
subarachnoid congestion with
focal hemorrhage,
heterotopia of cerebellar
white matter, broad and
spaced hallices, prominent
clitoris, poorly formed labia
Staals et al [18] 47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 18.2%
(22 colonies)
NA Normal liveborn, normal
development at age 3 y
Daniel et al [19] Case 6
47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 45.2%
(42 colonies)
NA TOP; abnormal abortus,
facial dysmorphisms,
abnormal nipples, unlobar
right lung, dysplastic
tricuspid valve, pleural
effusion
(continued on next page)
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Table 1 (continued)
Authors Cases Indication Amniocentesis studies Confirmatory studies Outcome and phenotype
Gentilin et al [20] 47,XX,þ12/46,XX Anxiety Amniocentesis:
T12 ¼ 17.6%
(17 colonies)
Retap: T12 ¼ 62.5%
(40 colonies)
Skin: T12 ¼ 2% (200 cells)
Cartilage: T12 ¼ 10% (200 cells)
TOP; normal abortus with
mild micrognathia
Present case 47,XX,þ12/46,XX AMA Amniocentesis:
T12 ¼ 39.1%
(23 colonies)
Retap: T12 ¼ 16.7%
(30 colonies)
interphase FISH:
T12 ¼ 17.8%
(45 uncultured
amniocytes)
Cord blood: T12 ¼ 0%
(40 cells)
Urinary cells:
interphase FISH: T12 ¼ 5%
(20 cells)
Normal liveborn, normal
development at age 6 mo
AMA ¼ advanced maternal age; CHD ¼ congenital heart defect; CVS ¼ chorionic villus sampling; FISH ¼ fluorescence in situ hybridization;
IUFD ¼ intrauterine fetal death; IUGR ¼ intrauterine growth restriction; mo¼month; MSAFP¼maternal serum a-fetoprotein; MShCG¼maternal serum human
chorionic gonadotrophin; NA ¼ not available; TOP ¼ termination of pregnancy; T12 ¼ trisomy 12; wk ¼ week; y ¼ year.
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born with a karyotype of 46,XY in skin fibroblasts, a karyo-
type of 47,XY,þ12[4]/ 46,XY[19] in chorionic villi, 5% (10/
200) mosaicism for trisomy 12 in spleen, intrauterine growth
restriction, oligohydramnios, Potter sequence, low-set ears,
lung and kidney hypoplasia, and neonatal death. Aughton et al
[24] reported a 9-year-old girl with a karyotype of 47,XX,þ12
[19]/48,XX,þ12,þ20[2]/46,XX[29] in skin fibroblasts, asym-
metric fullness of the soft tissues of the face, trunk and ex-
tremities, normal growth and low-normal development.
DeLozier-Blanchet et al [25] reported a 2-month-old girl
with a karyotype of 47,XX,þ12[7]/46,XX[38] in skin fibro-
blasts, congenital heart defects (large patent ductus arteriosus,
dysplastic pulmonary and tricuspid valves), facial dys-
morphisms, a two-vessel cord, widely spaced nipples, camp-
todactyly, overlapping fingers, pigmentary dysplasia and
neonatal death. Boulard et al [26] reported a 15-year-old girl
with 80% mosaicism for trisomy 12 in ovarian fibroblasts,
pituitary stalk interruption, polycystic ovary syndrome, facial
dysmorphisms, hypotonia, strabismus, conducting hearing loss
and atrial septal defect. Parasuraman et al [27] reported a fe-
male newborn with a karyotype of 47,XX,þ12[18]/46,XX[52]
in cord blood, polyhydramnios, echogenic bowel and dilated
cardiomyopathy on prenatal ultrasound, edema and low-set
ears at birth, and neonatal death. Al-Hertani et al [28] repor-
ted a 25-month-old girl with a karyotype of 47,XX,þ12[4]/
46,XX[17] in the skin fibroblasts from hyperpigmented and
hypopigmented regions, facial dysmorphisms, developmental
delay, microcephaly, unilateral sensorineural hearing loss, in-
testinal malrotation, hemihyperplasia, pigmentary dysplasia,
retinopathy and a vascular ring.
In summary, we present prenatal diagnosis and molecular
cytogenetic analysis of mosaic trisomy 12 using uncultured
and cultured amniocytes in a pregnancy with a favorable fetal
outcome. We demonstrate the usefulness of analyses of un-
cultured amniocytes by interphase FISH and aCGH for rapid
confirmation of low-level trisomy 12 mosaicism at amnio-
centesis, and by QF-PCR for rapid exclusion of UPD.Acknowledgments
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